Intellia Therapeutics Inc sell StockNews.com
Start price
27.12.25
/
50%
€7.90
Target price
27.12.26
-
Performance (%)
46.42%
Price
06.03.26
€11.57
Summary
This prediction is currently active. The price for Intellia Therapeutics Inc has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 27.12.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -0.772% | -0.772% |
| iShares Core DAX® | -6,02 % | -4,60 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % |
| iShares S&P 500 | -0,26 % | -0,84 % |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
18.01.26
18.01.26
-
18.01.27
18.01.27
9.15%
06.03.26
06.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.77
30.11.25
30.11.25
-
30.11.26
30.11.26
48.94%
06.03.26
06.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.06
08.11.25
08.11.25
-
08.11.26
08.11.26
27.76%
06.03.26
06.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.51
11.05.24
11.05.24
-
11.05.25
11.05.25
-67.08%
12.05.25
12.05.25